NURIX THERAPEUTICS, INC.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -34.2% | -34.2% | -24.6% |
| FY2022 | -59.4% | -59.4% | -43.3% |
| FY2023 | -71.8% | -71.8% | -40.5% |
| FY2024 | -36.7% | -36.7% | -28.9% |
| FY2025 | -49.1% | -49.1% | -38.4% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -34.2% | -34.2% | -24.6% |
| FY2022 | -59.4% | -59.4% | -43.3% |
| FY2023 | -71.8% | -71.8% | -40.5% |
| FY2024 | -36.7% | -36.7% | -28.9% |
| FY2025 | -49.1% | -49.1% | -38.4% |